Correction to: Trimodally treatment for stage IIIa NSCLC patients increases survival while not effecting surgical mortality or complexity
The original article [1] contained an error whereby all authors’ names were mistakenly inverted. This error has now been corrected.
Main Authors: | Dan Aravot, Yaron D. Barac, Efrat Krutzwald-Josefson, Aaron M. Allen, Dov Flex, Nir Peled, Mordechai R. Kramer, Yuri Peysakhovich, Milton Saute |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2019-02-01
|
Series: | Journal of Cardiothoracic Surgery |
Online Access: | http://link.springer.com/article/10.1186/s13019-019-0856-4 |
Similar Items
-
Trimodally treatment for stage IIIa NSCLC patients increases survival while not effecting surgical mortality or complexity
by: Dan Aravot, et al.
Published: (2019-01-01) -
Treatment-Related Predictive and Prognostic Factors in Trimodality Approach in Stage IIIA/N2 Non-Small Cell Lung Cancer
by: Branislav Jeremić, et al.
Published: (2018-02-01) -
Biomarkers for efficacy of adjuvant chemotherapy following complete resection in NSCLC stages I–IIIA
by: Sandra Wallerek, et al.
Published: (2015-06-01) -
Lymph node volume predicts survival but not nodal clearance in Stage IIIA-IIIB NSCLC.
by: Vishesh Agrawal, et al.
Published: (2017-01-01) -
Trimodal electroencephalogram during isoflurane anaesthesia
by: Lorenzo Dimpel
Published: (2016-04-01)